维百奥(北京)生物科技有限公司

400-001-2615
info@vicbio.com
产品名称 Human IL17A, IL-17F, IL17AF Antibody (Bimekizumab, Research Use)
目录号 NBR-0964
别名 IL-17A; IL-17; CTLA8
外观 Transparent Liquid
分子量 150kDa
CAS N/A
溶解度 Water, PBS, TBS Buffer,etc.
存储条件 Temp. -80℃
保存时间 see COA
备注1 CHO Expressed
备注2 Ab. Isotype - IgG
目录号 规格 价格 库存状态  
NBR-0964-100UG 100ug ¥550 请咨询
NBR-0964-1MG 1mg ¥3500 请咨询
NBR-0964-5MG 5mg ¥7500 请咨询



【产品概况】
产品名称:Human IL17A, IL-17F, IL17AF Antibody (Bimekizumab, Research Use)
产品编号:NBR-0964
针对靶点:IL17A, IL-17F, IL17AF
抗体药商品名:Bimekizumab
抗体药描述:Bimekizumab is the first-in-class monoclonal antibody designed to simultaneously target IL-17A and IL-17F. Bimekizumab is currently in clinical development for psoriasis, psoriatic arthritis, and ankylosing spondylitis, with promising results.

【产品参数】
产品外观:Transparent Liquid
分子量:~150kDa
CAS:N/A
溶解度:Water; PBS, TBS Buffer等
表达系统:CHO Expressed
抗体亚型:Ab. Isotype - IgG

 
【基因信息】
Gene Name: CTLA-8
Synonyms: IL-17A; IL-17; CTLA8
Target Description: IL17A (Interleukin 17A) is a Protein Coding gene. Diseases associated with IL17A include Allergic Contact Dermatitis and Bronchiolitis Obliterans. Among its related pathways are MIF Mediated Glucocorticoid Regulation and TGF-Beta Pathway. Gene Ontology (GO) annotations related to this gene include cytokine activity. An important paralog of this gene is IL17F.
Ensembl: ENSG00000112115
Uniprot: Q16552
 
相关产品